WallStSmart
COGT

Cogent Biosciences Inc

NASDAQ: COGT · HEALTHCARE · BIOTECHNOLOGY

$35.87
-1.29% today

Updated 2026-04-29

Market cap
$6.29B
P/E ratio
P/S ratio
861.15x
EPS (TTM)
$-2.16
Dividend yield
52W range
$5 – $44
Volume
2.1M

Cogent Biosciences Inc (COGT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-28.4%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-525.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-8.6%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-13.3%
2025-11-03
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-17$-0.56-10.3%$35.68$34.37-3.7%
2025-11-03$-0.50+4.2%$16.30$14.13-13.3%
2025-08-05$-1.27-116.5%$12.05$10.97-9.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.51$-0.56-10.3%
2025-09-30$-0.52$-0.50+4.2%
2025-06-30$-0.59$-1.27-116.5%
2025-03-31$-0.58$-0.52+9.0%
2024-12-31$-0.58$-0.09+84.6%$4.29M-23.2%
2024-09-30$-0.57$-0.64-13.2%
2024-06-30$-0.56$-0.59-5.4%
2024-03-31$-0.52$-0.62-19.2%
2023-12-31$-0.56$-0.63-12.5%$5.59M
2023-09-30$-0.50$-0.64-28.0%
2023-06-30$-0.54$-0.59-9.3%

Frequently asked questions

Has Cogent Biosciences Inc beaten earnings estimates?
Cogent Biosciences Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -28.4% over the last 4 quarters.
How does COGT stock react to earnings?
COGT stock has moved an average of -8.6% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.